Prior authorization processes may deny coverage for one medication while approving another
While medication alone wont solve this global health crisis, GLP-1 therapies can help millions overcome obesity and reduce its associated harms. The WHO did qualify its recommendations, saying endorsement is conditional due to limited data on their long-term efficacy and safety, maintenance and discontinuation, their current costs, inadequate health-system preparedness, and potential equity implications. The drugs should not be used by pregnant women, and should be paired with evidence-based interventions like healthy diets and physical activity, the guidelines also stress
4.1.1 Identifies strengths and opportunities in self and in others
The average monthly weight loss on GLP-1 medications settles into a predictable pattern during this phase
However, a potential drawback is that KD is typically low in dietary Trp [178], the precursor of several neuroprotective AhR ligands and serotonin pathway metabolites